Screening strategy for non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease, affecting approximately 25% of the general population worldwide, and is forecasted to increase global health burden in the 21st century. With the advancement of non-invasive tests for assessing and monitoring of stea...
Main Authors: | Saisai Zhang, Lung-Yi Mak, Man-Fung Yuen, Wai-Kay Seto |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Association for the Study of the Liver
2023-02-01
|
Series: | Clinical and Molecular Hepatology |
Subjects: | |
Online Access: | http://e-cmh.org/upload/pdf/cmh-2022-0336.pdf |
Similar Items
-
The latest evidence on the impact of fatty liver on liver-related outcomes and mortality in chronic hepatitis B
by: Xianhua Mao, et al.
Published: (2023-07-01) -
Assessment of Non-Alcoholic Fatty Liver Disease in Type 2 Diabetic Patients From South of Libya
by: Almahdi Melad Aljadi, Momen Abdou Alkhir, Mahmoud Hussein Milad
Published: (2020-10-01) -
Prevalence and Profile of Fibrosis in Diabetic Patients with Non-alcoholic Fatty Liver Disease and the Associated Factors
by: Ignatius Bima Prasetya, et al.
Published: (2017-04-01) -
Therapeutic Potentials of Reducing Liver Fat in Non-Alcoholic Fatty Liver Disease: Close Association with Type 2 Diabetes
by: Georgios Tsamos, et al.
Published: (2023-04-01) -
Prevalence of non-alcoholic fatty liver disease among diabetes, prediabetes and healthy population
by: Pratyush Kumar, et al.
Published: (2022-01-01)